2,736 press releases indexed under healthcare.
New targeted plasma cfDNA liquid biopsy testing options expand the FungiFlex ®menu, allowing clinicians to order targeted Pneumocystis jirovecii testing or combined mold and P. jirovecii detection based on the clinical question. ST. PAUL, Minn., July 15, 2026 /PRNewswire/ -- Zepto Life...
The Elsevier Foundation and The Lancet announced the three winning teams of the inaugural edition of The Lancet –Elsevier Foundation Evidence to Impact Awards. The Awards recognize research teams that go beyond publishing experimental findings: teams that have put implementation science to work, with communities, to change how health care is actually delivered. Today's health landscape faces complex challenges: from rising non-communicable diseases and infectious diseases to malnutr... Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=357704
TORONTO, ONTARIO - July 15, 2026 ( NEWMEDIAWIRE ) - NeuroThera Labs Inc. (TSXV: NTLX) (the " Company " or " NeuroThera "), a clinical-stage biotech company and a majority-owned subsidiary of SciSparc Ltd., today announced the initiation of its Phase IIb clinical trial site at Hannover Medical School, Hanover (“MHH”), Germany, for SCI-110, its proprietary cannabinoid-based treatment candidate for Tourette Syndrome (TS) in adults. The trial, which previously received regulatory clearance from Germany’s Federal Institute for Drugs and Medical Devices and MHH's ethics committee, is now advancing towards the next stage at Hannover Medical School, one of the key clinical sites of the study. SCI-110 combines dronabinol with the endocannabinoid-like palmitoylethanolamide in an innovative one dosag
Wednesday 15 July, 2026 Booking is now live for the Connected Lives training programme, with events in 20 locations across Scotland and online. The new training programme from Befriending Networks kicks off in Edinburgh on Tuesday 11 August and will continue until February 2027, visiting 20 towns and cities across Scotland. Four online sessions will also be available for those who are unable to attend in person. Connected Lives training is free and open to staff and volunteers at third sector organisations based in Scotland who want to feel more confident supporting people living with dementia. Research suggests that social isolation is a key risk factor for developing dementia. Alzheimer’s Research UK estimates that if everyone kept socially connected, there would be five fewer cases of d
David Seaman, the ex-England goalkeeper nicknamed 'Safe Hands', is encouraging football fans across the UK to put their heart health first by popping to their local Tesco Pharmacy for a free blood pressure check. - - The supermarket has teamed up with the British Heart Foundation to offer more than 50,000 blood pressure check appointments per week across over 350 Tesco Pharmacies so fans can get themselves checked as they shop for their big match essentials. - - The quick and simple test tha... Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=357699
Mitsui Chemicals, Inc. (Tokyo:4183; President & CEO: ICHIMURA Satoshi; “Mitsui Chemicals”) has decided to integrate its dental 3D printing business and some dental materials business in Japan into its subsidiary, Sun Medical Co., Ltd. (Head Office: Moriyama City, Shiga; President & CEO: SUZUKI Takefumi; “Sun Medical”). Mitsui Chemicals positions Sun Medical as the core of its dental 3D printing business and will continue to strengthen its capabilities. - - Kulzer Japan Co., Ltd. (Head Offic... Read the full story at https://www.webwire.com/ViewPressRel.asp?aId=357695
(PR-inside.com) ATLANTA, GA / ACCESS Newswire / July 15, 2026 / While remote work has become a permanent part of life for many professionals,Ankle & Foot Centers of Americais encouraging employees to pay closer attention to their foot health. Years after the work-from-home boom, podiatrists continue to see patients experiencing foot pain and other lower extremity issues related to prolonged sitting, reduced activity, and unsupportive footwear. Working from home often means spending long hours at a desk while barefoot or wearing slippers that lack proper arch support. Combined with hard flooring and decreased daily movement, these habits can contribute to conditions such ..
NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, July 15, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before...
— Peer-reviewed publication details RAG-17's robust translation from "bench to bedside," validating the proprietary SCAD™ delivery platform for CNS-targeted RNAi therapies — — First-in-Human trial met primary safety endpoints with no Serious Adverse Events (SAEs); demonstrated mean...
Issued on behalf of MindWalk Holdings Corp. MindWalk Holdings Corp. (NASDAQ: HYFT) heads into its fourth-quarter and full-year results with fresh index inclusion, an expanded patent estate, and AI-designed programs aimed at two of medicine's biggest frontiers: GLP-1 metabolic health and...
VANCOUVER, BC, July 15, 2026 /PRNewswire/ -- Intiveo, the patient engagement platform built for dental and oral surgery practices, today released its 2026 Dental Patient Engagement Report, a benchmark study drawn from communication and engagement data across more than 2,500 practices...
TEL AVIV, Israel, July 15, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that its subsidiary NeuroThera Labs Inc. (TSXV: NTLX) ("NeuroThera"), a clinical-stage pharmaceutical company focused on developing novel treatments for central nervous system disorders, announced the initiation of its Phase IIb clinical trial site at Hannover Medical School, Hanover, Germany (“MHH”), for SCI-110, its proprietary cannabinoid-based treatment candidate for Tourette Syndrome (TS) in adults.